Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.92 EUR | 0.00% | +2.50% | +16.59% |
26/04 | Agronomics investee raises additional EUR8 million | AN |
26/04 | Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product | MT |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 54.67 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.59% | 29.52M | - | ||
+3.75% | 36.06B | B | ||
+14.25% | 35.6B | B | ||
0.00% | 18.31B | - | - | |
+3.03% | 5.36B | - | C | |
+0.62% | 3.14B | - | B- | |
+10.79% | 2.87B | D+ | ||
+18.81% | 2.82B | C- | ||
-17.26% | 2.29B | C+ | ||
+4.02% | 1.24B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SPRING Stock
- Ratings Springvest Oyj